Cargando…

The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery

PURPOSE OF REVIEW: Iatrogenic ovarian damage can occur after chemotherapy, radiotherapy and surgery for cancer as well as for non-malignant conditions. This review describes the effects of such treatment on antimullerian hormone (AMH) and the implications of the fall in AMH in relation to ovarian fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Queenie Ho Yan, Anderson, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott, Williams & Wilkins 2018
Materias:	REPRODUCTIVE ENDOCRINOLOGY: Edited by Wendy Kuohung
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226218/ https://www.ncbi.nlm.nih.gov/pubmed/30299433 http://dx.doi.org/10.1097/MED.0000000000000447

Ejemplares similares

SAT-002 Does the Age of Women Influence the Evaluation of Ovarian Reserve Through the Determination of Antimullerian Hormone and Follicle Count?
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

Maximizing the clinical utility of antimüllerian hormone testing in women's health
por: Leader, Benjamin, et al.
Publicado: (2014)

SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome
por: Hoyos, Luis R, et al.
Publicado: (2020)

Point-of-care diagnostics: extending the laboratory network to reach the last mile
por: Drain, Paul K., et al.
Publicado: (2017)

An online tool for predicting ovarian responses in unselected patients using dynamic inhibin B and basal antimüllerian hormone levels
por: Ma, Congcong, et al.
Publicado: (2023)

Categorization of differences of sex development among Egyptian children and the role of antimullerian hormone and inhibin B
por: Abdelghaffar, Shereen, et al.
Publicado: (2023)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

SUN-002 Hormonal Profile of Ovarian Sertoli-Leydig Cell Tumor
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve
por: Tal, Reshef, et al.
Publicado: (2013)

SAT360 Ovarian Vein Sampling in a Pre-menopausal Woman with Hyperandrogenism: Characterization of Hormonal Profiles
por: Hu, Tina Y, et al.
Publicado: (2023)

FRI420 Prevalence Of Ovarian Hormone Suppression Is High Among Regularly Cycling Reproductive-aged Women With Overweight Or Obesity
por: Caldwell, Annie, et al.
Publicado: (2023)

Antimüllerian Hormone Levels of Infants with Premature Thelarche
por: Muratoğlu Şahin, Nursel, et al.
Publicado: (2019)

Longitudinal antimüllerian hormone and its correlation with pubertal milestones
por: Smith, Meghan B., et al.
Publicado: (2021)

OR25-6 Higher Ovarian Androgen Responses to Ambient Luteinizing Hormone and to Recombinant Human Chorionic Gonadotropin Stimulation in Late Pubertal Girls with Obesity
por: Burt Solorzano, Christine, et al.
Publicado: (2019)

OR03-01 Functional Rescue Of Trafficking-Defective Mutant Follicle-Stimulating Hormone Receptors (FSHR) Leading To Premature Ovarian Failure With The Pharmacoperone CAN1405
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2023)

Antimullerian Hormone Changes after Laparoscopic Ovarian Cystectomy for Endometrioma Compared with the Nonovarian Conditions
por: Tanprasertkul, Chamnan, et al.
Publicado: (2014)

Peripubertal changes in circulating antimüllerian hormone levels in girls
por: Lashen, Hany, et al.
Publicado: (2013)

Antimüllerian Hormone as a Tool to Predict the Age at Menopause
por: Chatziandreou, Efstathia, et al.
Publicado: (2023)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters
por: Pulsiano, Sune Wolf, et al.
Publicado: (2022)

OR11-3 Evidence for Preserved Ovarian Reserve in Transgender Men Receiving Testosterone Therapy: Anti-Mullerian Hormone Serum Levels Decrease Modestly after One Year of Treatment
por: Yaish, Iris, et al.
Publicado: (2019)

Discrepancies between Antimullerian Hormone and Follicle Stimulating Hormone in Assisted Reproduction
por: Hussain, Munawar, et al.
Publicado: (2013)

Patient Characteristics Associated With the Receipt of Hormone Therapy Among Transgender Patients in the Veterans Health Administration
por: Wong, Denise H, et al.
Publicado: (2021)

SAT-231 A Case of Small Cell Ovarian Cancer, Hypercalcemic Type, in Pregnancy
por: Polu, Shruti, et al.
Publicado: (2019)

MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome
por: Mody, Armaiti, et al.
Publicado: (2020)

Cyclical Premenstrual Psychosis - Sometimes It Is Your Hormones
por: Rawal, Malika, et al.
Publicado: (2021)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

OR11-03 NT-814, a Non-Hormonal Dual Neurokinin 1,3 Receptor Antagonist Markedly Improves Vasomotor Symptoms in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Study (SWITCH-1)
por: Simon, James, et al.
Publicado: (2020)

ODP600 Is this a case of surreptitious hormonal supplements?
por: Rimal, Priya, et al.
Publicado: (2022)

LBMON232 A Hairy Situation: Ovarian Sex Cord Stromal Tumor As A Rare Cause Of Hyperandrogenism
por: Syed, Hasan, et al.
Publicado: (2022)

SAT361 A Rare Case of Ovarian Steroid Cell Tumor in a Patient With Known Polycystic Ovarian Syndrome
por: Aluko, Oluwatomisin A, et al.
Publicado: (2023)

Antimullerian Hormone Level and Endometrioma Ablation Using Plasma Energy
por: Roman, Horace, et al.
Publicado: (2014)

Virilization Secondary to an Ovarian Leydig Cell Tumor
por: Symczyk, Oksana, et al.
Publicado: (2021)

MON-209 Systemic and Hypothalamic Hyperandrogenism Emerges Following Elimination of Ovarian and Extra-Ovarian Sources of Estradiol in Female Marmoset Monkeys
por: Kraynak, Marissa, et al.
Publicado: (2019)

SAT-LB1 Detection of Serum Macro-Luteinizing Hormone
por: Ogura-Ochi, Kanako, et al.
Publicado: (2020)

MON-039 Prenatal Anti-Mullerian Hormone (pAMH) Exposure in Mice Induces Changes in Pubertal Onset, Fertility, and Stress Response in Both Male and Female Offspring
por: Ho, Emily V, et al.
Publicado: (2020)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

SUN-231 Marijuana Use Correlates with Hormonal Imbalance in Infertile Men
por: Teixeira, Thiago, et al.
Publicado: (2019)

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

Hormonal Replacement Therapy in Premenopausal Women With Hypogonadism: An Analysis of Prescriber Practices
por: Martirossian, Alexandra Nicole, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqn4roofangsje912ukpe9uqn8